Imagine a blood cell count device that needs no blood and is the size of a cell phone. Innovative optics sense through the skin, and count white cells as they flow past a miniature lens. The white cell count is the first line indicator for medical applications ranging from chemotherapy management to the detection of life threatening infection in a targeted world population of 4 billion people.
Thanks to VMS we connected with great mentors from biotech start-ups, medical device companies and the pharma industry. Their advice helped us raise our first two commercially-oriented grants. Additionally, they guided us on identifying key technical and commercial risks, interviewing potential clients and setting a sensible fundraising plan.